Gene · 619554
Papers2,728
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,728
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-4478 Accelerates Nucleus Pulposus Cells Apoptosis Induced by Oxidative Stress by Targeting MTH1. | Spine (Phila Pa 1976) | 2023 | 36130054 | PubTator, text mining | PubMed |
| Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis. | Cancer Med | 2023 | 36057947 | PubTator, text mining | PubMed |
| Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes. | Neural Regen Res | 2023 | 36018185 | PubTator, text mining | PubMed |
| Vitamin D modulates inflammatory response of DENV-2-infected macrophages by inhibiting the expression of inflammatory-liked miRNAs. | Pathog Glob Health | 2023 | 35850625 | PubTator, text mining | PubMed |
| Circ_CSPP1 Regulates the Development of Non-small Cell Lung Cancer via the miR-486-3p/BRD9 Axis. | Biochem Genet | 2023 | 35678942 | PubTator, text mining | PubMed |
| Role of epigenetic abnormalities and intervention in obstructive sleep apnea target organs. | Chin Med J (Engl) | 2023 | 35245923 | PubTator, text mining | PubMed |
| Non-coding RNAs and type 2 diabetes mellitus. | Arch Physiol Biochem | 2023 | 33155514 | PubTator, text mining | PubMed |
| End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO. | Front Oncol | 2022 | 36798690 | PubTator, text mining | PubMed |
| Exosomes and cancer immunotherapy: A review of recent cancer research. | Front Oncol | 2022 | 36727049 | PubTator, text mining | PubMed |
| Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet? | Front Oncol | 2022 | 36686736 | PubTator, text mining | PubMed |
| Identification of extremely GC-rich micro RNAs for RT-qPCR data normalization in human plasma. | Front Genet | 2022 | 36685854 | PubTator, text mining | PubMed |
| Bibliometric analysis of scientific papers on extracellular vesicles in kidney disease published between 1999 and 2022. | Front Cell Dev Biol | 2022 | 36684427 | PubTator, text mining | PubMed |
| Circulating microRNAs Showed Specific Responses according to Metabolic Syndrome Components and Sex of Adults from a Population-Based Study. | Metabolites | 2022 | 36676927 | PubTator, text mining | PubMed |
| Integrative Analysis of miRNAs Involved in Fat Deposition in Different Pig Breeds. | Genes (Basel) | 2022 | 36672834 | PubTator, text mining | PubMed |
| Obstructive Sleep Apnea: A Look towards Micro-RNAs as Biomarkers of the Future. | Biology (Basel) | 2022 | 36671757 | PubTator, text mining | PubMed |
| Overview of triple negative breast cancer prognostic signatures in the context of data science-driven clinico-genomics research. | Ann Transl Med | 2022 | 36660729 | PubTator, text mining | PubMed |
| Extracellular vesicle characteristics and microRNA content in cerebral palsy and typically developed individuals at rest and in response to aerobic exercise. | Front Physiol | 2022 | 36620222 | PubTator, text mining | PubMed |
| MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression. | Front Cell Dev Biol | 2022 | 36619870 | PubTator, text mining | PubMed |
| miR-576-5p Promotes the Proliferation of Papillary Thyroid Carcinoma through the MAPK4-AKT Pathway. | Int J Anal Chem | 2022 | 36618768 | PubTator, text mining | PubMed |
| Effects of Two Different School-Based Training on Serum miR15b Expression and Lipid Profile of Adolescents with Obesity. | Int J Prev Med | 2022 | 36618534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/619554/papers?page=18